APOLLO Trial: Magnitude And Duration of Effects of A Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial
C. Michael Gibson and Steven Nissen discuss the APOLLO Trial presented at ACC 2022.
Advertisement
Sign In
New at TCTMD? Register today!
Forgot Your Password?
Enter the email you used to register to reset your password.
Search TCTMD
cme